Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis

NCT07308392 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis

Interventions

DRUG: HRS-7249 injection set
DRUG: SHR-1918 injection set
DRUG: HRS-7249 injection placebo set
DRUG: SHR-1918 injection placebo set

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.